O:\JPETREA\1Q10Q\12B2599A.DOC
UNITED STATES OMB APPROVAL
SECURITIES AND EXCHANGE COMMISSION OMB
Washington, D.C. 20549 Num
FORM 12b-25 ber
: 3235-0058
Exp
ire
s:
Est
ima
ted
ave
rag
e
bur
den
hou
rs
per
res
pon
se 2.50
NOTIFICATION OF LATE FILING SEC FILE NU
MBER
001-
13460
(Check CUSIP NUMBER
One): o Form 10-K o 190495 10 1
Form 20-F o Form 11-K x Form 10-Q o Form N-
SAR
For Period Ended: March 31, 1999
[ ] Transition Report on Form 10-K
[ ] Transition Report on Form 20-F
[ ] Transition Report on Form 11-K
[ ] Transition Report on Form 10-Q
[ ] Transition Report on Form N-SAR
For the Transition Period Ended:
Read Instruction (on back page) Before Preparing Form. Please Print or T
ype.
Nothing in this form shall be construed to imply that the Commission has
verified any information contained herein.
If the notification relates to a portion of the filing checked above,
identify the Item(s) to which the notification relates:
N/A
PART I - REGISTRANT INFORMATION
Coastal Physician Group, Inc.
Full Name of Registrant
N/A
Former Name if Applicable
2828 Croasdaile Drive
Address of Principal Executive Office (Street and Number)
Durham, North Carolina 27705
City, State and Zip Code
PART II - RULES 12b-25(b) AND (c)
If the subject report could not be filed without unreasonable effort or
expense
and the registrant seeks relief pursuant to Rule 12b-25(b), the following
should
be completed. (Check box if appropriate)
(a The reasons described in reasonable detail in Part III of this
) form
could not be eliminated without unreasonable effort or expense;
x (b The subject annual report, semi-annual report, transition
) report on Form 10-K, Form 20-F, 11-K or Form N-SAR
or portion thereof, will be filed on or before the fifteenth
calendar day following the prescribed due date; or the subject
quarterly report or transition report on Form 10-Q, or portion
thereof will be filed on or before the fifth calendar day
following the prescribed due date; and
(c The accountant's statement or other exhibit required
) by Rule 12b-25(c) has been attached if applicable.
PART III - NARRATIVE
State below in reasonable detail the reasons why Forms 10-K, 20-F, 11-K,
10-Q, N-SAR, or the transition report or portion thereof, could not be
filed
within the prescribed time period.
the registrant attempted a timely filing.
However, the CCC Code was
Inconsistent with the CIK Code.
(Attach Extra Sheets if Needed)
SEC 1344 (6/94)
PART IV - OTHER INFORMATION
(1) Name and telephone number of person to contact in regard to this
notification
W. RANDALL DICKERSON
Executive Vice President and Chief Financial Officer (919)
383-0355
(Name) (Area Code)
(Telephone Number)
(2) Have all other periodic reports required under Section 13 or 15(d)
of the Securities Exchange Act of 1934 or Section 30 of the
Investment Company Act of 1940 during the preceding 12 months
or for such shorter period that the registrant
was required to file such report(s)
been filed? If answer is no, identify reports(s). xYes
(3) Is it anticipated that any significant change in results of
operations
from the corresponding period for the
last fiscal year will be reflected by the earnings statements to
be included
in the subject report or portion thereof?xYes
If so, attach an explanation of the anticipated change, both
narratively and quantitatively, and, if appropriate,
state the reasons why a reasonable estimate of the results
cannot be made.
The current period loss is expected to be
approximately one-half
of the loss for the previous year's period.
Coastal Physician Group, Inc.
(Name of Registrant as Specified in Charter)
has caused this notification to be signed on its behalf by the undersigned
hereunto duly authorized.
Date May 17, 1999 By /s/ W. Randall dickerson
W. Randall Dickerson
Executive Vice President and Chief
Financial Officer
INSTRUCTION: The form may be signed by an executive officer of the
registrant or by any other duly authorized representative. The name and
title of the person signing the form shall be typed or printed beneath the
signature. If the statement is signed on behalf of the registrant by an
authorized representative (other than an executive officer), evidence of
the representative's authority to sign on behalf of the registrant shall
be filed with the form.
ATTENTION
